Canada markets open in 5 hours 41 minutes

Canntab Therapeutics Limited (PILL.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.01500.0000 (0.00%)
At close: 09:30AM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 583.64k
Enterprise Value 2.57M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.02
Price/Book (mrq)N/A
Enterprise Value/Revenue 17.81
Enterprise Value/EBITDA -1.30

Trading Information

Stock Price History

Beta (5Y Monthly) 0.89
52-Week Change 3-97.41%
S&P500 52-Week Change 3-13.21%
52 Week High 30.6000
52 Week Low 30.0000
50-Day Moving Average 30.0160
200-Day Moving Average 30.1013

Share Statistics

Avg Vol (3 month) 329.33k
Avg Vol (10 day) 34.9k
Shares Outstanding 538.91M
Implied Shares Outstanding 6N/A
Float 833M
% Held by Insiders 113.74%
% Held by Institutions 10.00%
Shares Short (Feb 14, 2023) 4329
Short Ratio (Feb 14, 2023) 40.02
Short % of Float (Feb 14, 2023) 4N/A
Short % of Shares Outstanding (Feb 14, 2023) 40.00%
Shares Short (prior month Jan 12, 2023) 4766

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Mar 07, 2016
Last Split Factor 21:200
Last Split Date 3Apr 19, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends May 30, 2022
Most Recent Quarter (mrq)Nov 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,694.79%

Management Effectiveness

Return on Assets (ttm)-82.11%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)144.09k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-89.70%
Gross Profit (ttm)-939.01k
EBITDA -3.42M
Net Income Avi to Common (ttm)-3.36M
Diluted EPS (ttm)-0.0900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)55.32k
Total Cash Per Share (mrq)0
Total Debt (mrq)2.04M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.21
Book Value Per Share (mrq)-0.05

Cash Flow Statement

Operating Cash Flow (ttm)-2.12M
Levered Free Cash Flow (ttm)-875.1k